Citation Impact
Citing Papers
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
2001 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Optimal Management of the T1G3 Bladder Cancer
2005
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Radical cystectomy for elderly patients with bladder carcinoma
1998
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Prospective Health-related Quality of Life Analysis for Patients Undergoing Radical Cystectomy and Urinary Diversion
2014
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Long-term results of standard procedures in urology: the ileal neobladder
2006
Metabolic and functional consequences of urinary reconstruction with bowel
2003
Prevention of Venous Thromboembolism in General Surgical Patients
1988
Perioperative Management of Antithrombotic Therapy
2012 Standout
Guidelines on Bladder Cancer
2002
The Z‐shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
2011
Renal-Cell Carcinoma
1996 Standout
A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?
2004
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
1988
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines
2006 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
T1G3 Bladder Tumours: The Case for Conservative Treatment
2003
Perioperative Management of Patients Receiving Oral Anticoagulants
2003
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery
2004
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
2013 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Distressful symptoms after radical radiotherapy for urinary bladder cancer
2002
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Prevention of Venous Thromboembolism
2004 Standout
Fluid intake and epidemiology of urolithiasis
2003
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Prevention of Venous Thromboembolism
2008 Standout
Urinary Diversions after Cystectomy: The Association of Clinical Factors, Complications and Functional Results of Four Different Diversions
2007
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Lymphedema beyond breast cancer
2010 Standout
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
2007 Standout
Clinical Indications and Outcomes with Nerve-sparing Cystectomy in Patients with Bladder Cancer
2005
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Prevention of Venous Thromboembolism
1998
The rise and rise of drug delivery
2005
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
2012
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery
2000
Urinary Diversion Via a Continent Ileal Reservoir: Clinical Results in 12 Patients
1982 Standout
FUNCTIONAL RESULTS OF ORTHOTOPIC ILEAL NEOBLADDER WITH SEROUS-LINED EXTRAMURAL URETERAL REIMPLANTATION: EXPERIENCE WITH 450 PATIENTS
2001
Maturation of the hemostatic system during childhood
1992 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Intravesical Versus Intravesical Plus Intradermal Bacillus Calmette-Guerin: A Prospective Randomized Study In Patient With Recurrent Superficial Bladder Tumors
1996
Prevention of Venous Thromboembolism
1981
Prevention of Venous Thromboembolism
1992
Factor V Leiden (G1691A) and Prothrombin Gene G20210A Mutations as Potential Risk Factors for Venous Thromboembolism after Total Hip or Total Knee Replacement Surgery
2002 StandoutNobel
Prevention of postoperative deep-vein thrombosis by low-dose heparin in open prostatectomy
1980
Bladder Cancer
2020 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The Kock Ileal Neobladder: Updated Experience in 295 Male Patients
1996
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
2000 Standout
Long-Term Outcome of Ileal Conduit Diversion.
2003
Lower Urinary Tract Reconstruction Following Cystectomy In Women Using The Kock Ileal Reservoir With Bilateral Ureteroileal Urethrostomy: Initial Clinical Experience
1994
Cancer treatment and survivorship statistics, 2016
2016 Standout
Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis on 13,185 Patients
2012
INHIBITION OF BLADDER CARCINOMA CELL ADHESION BY OLIGOPEPTIDE COMBINATIONS IN VITRO AND IN VIVO
2002
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes
2013
Prospective comparison of quality‐of‐life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model
2013
Cancer treatment and survivorship statistics, 2019
2019 Standout
Pathogenesis and Prophylaxis of Postoperative Thromboembolic Disease in Urological Pelvic Surgery
1995
Low-Molecular-Weight Heparins
1997 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low‐dose heparin
1980
BCG immunotherapy for superficial bladder cancer
2001
Prevention of Venous Thromboembolism
1995
Enlargement of Regional Lymph Nodes in Renal Cell Carcinoma is Often not Due to Metastases
1990
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Lymphography and Pelvic Lymphadenectomy in Carcinoma of the Prostate
1976
Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node Metastasis
2002 Standout
Works of E. Zingg being referenced
Effects of Nasal Calcitonin on Bone Mineral Density following Parathyroidectomy in Patients with Primary Hyperparathyroidism
2003
Bladder Substitution with an Ileal Low-Pressure Reservoir
1988
Three Years' Experience with an Ileal Low Pressure Bladder Substitute
1989
Analysis of early failures after intravesical instillation therapy with bacille Calmette‐Guerin for carcinoma in situ of the bladder
1995
Ileal Bladder Substitute:Antireflux Nipple or Afferent Tubular Segment?(1)
1991
Influence of Calcium Content in Mineral Water on Chemistry and Crystallization Conditions in Urine of Calcium Stone Formers
1988
ILEAL ORTHOTOPIC BLADDER SUBSTITUTES
1997
Summary of 10 years' experience with an ileal low-pressure bladder substitute combined with an afferent tubular isoperistaltic segment
1996
Urinary Diversion in the Elderly Patient
1980
Controlled Prevention of Post-Operative Thrombosis in Urological Diseases with Depot Heparin
1975
Continent Cecoileal Conduit: Preliminary Report
1977
Computerized tomography versus angiography in the staging of malignant renal neoplasm
1981
Bladder reconstruction with bowel after radical cystectomy
1992
Lymphography in Carcinoma of the Prostate
1974
A newer form of bladder substitute based on historical perspectives.
1988
Electroresection of the Prostate in Patients Treated with Heparin
1980
Exfoliative Cytology after Transurethral Resection of Superficial Bladder Tumours
1985
Computed Tomography in Staging of Carcinoma of the Urinary Bladder
1982